Explore more publications!

Guinea Bissau Health Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Health Bulletin.

Press releases published on November 5, 2025

Synergy CHC Corp Expands FOCUSfactor® Functional Beverage Distribution Across Arkansas Through Partnership with C&M Sales
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
BioAtla to Announce Third Quarter 2025 Financial Results and Provide Business Highlights on November 13, 2025
Beyond Air® Secures Up to $32 Million to Accelerate Growth
Kailera Therapeutics to Participate in Upcoming November Investor Conferences
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results
LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Pacira BioSciences Concludes Patient Enrollment in Part A of Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee
23andMe Research Institute Appoints Kael Reicin as Chief Financial Officer
Ardelyx to Participate at the Jefferies Global Healthcare Conference in London
Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025
MannKind Corporation Reports Third Quarter 2025 Financial Results and Provides Business Update
Curonix Strengthens Executive Leadership with Appointment of Leading Medical Device Executive Russell Fleeger as Chief Financial Officer to Drive Next Stage of Growth
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
MediWound to Report Third Quarter 2025 Financial Results
Altimmune to Participate in Two Upcoming Investor Conferences
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
Crescent Biopharma to Present at November Investor Conferences
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions